- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05259267
Online Group Therapy for Breast Cancer
Investigation of the Effectiveness of an Online Group Therapy Program for Post-Traumatic Growth in Women With Breast Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Preliminary studies to development of the programs Before the development of protocol of the current treatment programs, the investigators reviewed related literature and published a systematic review about the related factors for PTG in women with breast cancer. After obtaining the ethical approval the study coordinator interviewed with eight women via telephone to explore the experiences of women with breast cancer. The investigators determined the needs and possible challenges of the illness. Besides, previous similar treatment programs were examined in detail. Later, the investigator developed the study protocol with the supervisor and send the content of the treatment programs to five specialists who have MD in clinical psychology and got feedback and the investigators revisited final version of the treatment programs.
In brief, the research hypotheses are 1) both online group therapy for PTG and online support groups will show better PTG levels and rumination scores, and other secondary measurements (such as psychological distress, heart rate variability, disclosure of distress) than wait-list control. 2) Participants who in online group therapy for PTG will improve better PTG and rumination scores, and secondary measurements' scores compared with the participants in online support groups. 3) The benefits of the treatment programs will be endured for 1-month follow-up measure.
Procedure Ethical approval: This study was approved by the institutional review board of Eskisehir Osmangazi University. All study participants gave written informed consent. Announcements will be posted in various departments of the hospital to participate in the research. First of all, volunteer participants will be assessed through the phone and informed about the research process. If they agree to participate, the investigators will organize a detailed interview. In this interview one of the researchers of the study who is a psychiatrist will apply SCID to eliminate the other possible mental disorder. Patients who meet the criteria will be informed about the group and informed consent forms will be obtained. Before beginning of the treatment program, baseline measurement and ECG Holter measurement will be scheduled by the telephone. After completing baseline measurement, the participants will then be randomly allocated to one of the three groups.
The online treatment programs will be delivered to groups of 6-8 participants by a psychologist and psychiatrist (therapist and co-therapist), eight weekly online sessions. Online sessions will be delivered through an online video-conferencing software (ZOOM). Sample size is determined by g-power analysis. For three-arm randomized controlled trial we plan to recruit at least 51 participants (each group should have at least 17 participants). Before the beginning of the study, the participants will be informed about online video-conferencing platform. The investigators will send a video about the use of platform and also step by step user manual. Each participant in treatment programs should join at least six sessions. If the participants could not complete six sessions, the investigators will admit them drop-out (This information will be declared during the interviews and written informed consent). The investigators will use SPSS 23.0 Package Program for Social Sciences. The descriptive analysis will be performed for frequencies of socio-demographics and clinical information such as cancer stage, treatments. To test the hypothesis, the investigators will conduct a repeated measure ANOVA. The investigators will employ intention to treat and as treated analysis.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cennet Yastıbaş-Kaçar, MD
- Phone Number: +905346320490
- Email: cennet.yastibas@deu.edu.tr
Study Locations
-
-
-
Eskişehir, Turkey, 26040
- Recruiting
- Eskisehir Osmangazi University Faculty of Medicine
-
Contact:
- Cennet Yastıbaş-Kaçar, MD
- Phone Number: +905346320490
- Email: cennet.yastibas@deu.edu.tr
-
Principal Investigator:
- İmran Gökçen Yılmaz-Karaman, Dr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- women who have been diagnosed with breast cancer for the first and only
- women who have been diagnosed breast cancer in 2018 and later (past four years)
- stage I, II and III patients
- ability to use internet
- having a personal computer or tablet with a camera and microphone
- describing cancer as a stressful life event (using PCL-5 to assess post-traumatic stress level)
Exclusion Criteria:
- recurrence of breast cancer,
- second cancer,
- severe psychological or physical comorbidity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Online Group Therapy for PTG
It consists of eight sessions that occur during app.
90 minutes.
A group therapist and a cotherapist will lead the therapy sessions.
There will be one session per a week.
|
Online Group Therapy for PTG consists of eight sessions.
Each sessions have specific themes.
First session: psychoeducation, normalization of the experiences and emotions.
Second session: emotion regulation skills.
Third session: awareness of the negative thoughts that make patients worried, anxious, feared.
Forth session: restructuring of the thoughts and practicing mindfulness technics.
5. session: practicing of self-disclosure skills 6. session: creating a breast cancer story with balancing losses and gains.
7. session: sharing of the effects of breast cancer on life and developing new life priorities 8. session: making life meaning and developing new life goals.
|
|
Active Comparator: Online Support Group
It consists of eight sessions that occur during app.
90 minutes.
A group therapist and a cotherapist will lead the therapy sessions without using any psychological methods.
There will be one session per a week.
|
Online support groups also consist of eight sessions.
1. session: introducing the program and learning the expectancies 2. session: sharing what is known about breast cancer 3. session: risk and protective factors for breast cancer 4. session: sharing side effects of surgical operation and treatments 5. session: sharing the reactions of family, close friends 6. session: patient-doctor relationship and also sharing the challenges and facilitators of healthcare system 7. session: sharing the current position in the treatment and of what has been done for improvement 8. session: sharing the reliable information sources for breast cancer and close
|
|
No Intervention: Wait-list
We used a wait-list as a control group.
After each participants in both online PTG group therapy and online support group completed the interventions, wait-list will be randomly assigned to one of these two interventions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Post-traumatic Growth Inventory
Time Frame: Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
The Turkish version of Post-traumatic Growth Inventory to measure PTG levels of the patients will be used.
It is compromised of 21 item and scored ranging from 0 to 5. Higher scores refer higher PTG level.
|
Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
|
Change in Event-Related Rumination Inventory (ERRI)
Time Frame: Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8 (after completing eight-week intervention), and 1-month follow-up.
|
The Turkish version of Event-Related Rumination Inventory (ERRI) that is reliable and validated measure will be used to assess rumination of the breast cancer.
It has 20 items and two sub-scale; intrusive and deliberate rumination.
The scores are changing from 0 to 3.
|
Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8 (after completing eight-week intervention), and 1-month follow-up.
|
|
PTSD Checklist for DSM-5 (PCL-5)
Time Frame: Baseline measurement to deciding to join the treatment programs
|
It will be used to asses stressful level of breast cancer to participate the treatment programs.The 20-item self-report measure of PTSD scored from 0 to 4, and yielding a scale score range of 0-80.
|
Baseline measurement to deciding to join the treatment programs
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Depression Anxiety and Stress Scale (DASS-21)
Time Frame: Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
The Turkish version of Depression Anxiety and Stress Scale which is a reliable and validated study result will be used for secondary outcome.
It consists of 21 items and three sub scale.
Higher scores of each sub-scale sign higher distress level.
|
Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
|
Change in Heart-Rate Variability
Time Frame: Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
Holter electrocardiogram (ECG) Monitoring will be used to asses physical effects of intervention programs.
It will be used 24 hour holter.
A cardiologist will read the holter ECG results.
Heart rate will be analyzed using the standard deviation of sequential interbeat intervals averaged over 5 min epochs (SDANN)
|
Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
|
Change in Distress Disclosure Index
Time Frame: Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
It will be used to evaluate emotional expression and repression.
Our treatments may indirectly have impact on disclosure of the patients' emotions.
The Turkish version of Distress Disclosure Index which has good reliability and variability scores has 12 items and rated on a five-point scale (scored 1-5).
Higher scores refer higher expression of emotions.
|
Baseline measurement before the treatment programs begin (pre-intervention),post-intervention at week 8(after completing eight week intervention), and 1-month follow-up.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Cennet Yastıbaş-Kaçar, MD, Dokuz Eylül University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121K686
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Online Group Therapy for PTG
-
Instituto de Cardiologia do Rio Grande do SulCompletedDepressive Symptoms | Anxiety State | Psychological Well-BeingBrazil
-
Ankara Medipol UniversityCompletedFeeding and Eating Disorders | Child Behavior Problem | Feeding Behavior | Occupational Therapy | Online InterventionTurkey
-
Universitat Jaume IMinisterio de Ciencia e Innovación, SpainCompletedSexual Compulsive Behavior Disorder | Cybersex Addiction | Online Compulsive Sexual BehaviorSpain
-
Ankara Medipol UniversityActive, not recruitingLong-Term Effect of Online Occupational Therapy-Based Parent Training on Feeding Problems in InfantsFood Neophobia | Feeding Problems | Feeding DifficultiesTurkey (Türkiye)
-
Umeå UniversityCompletedDepression | Anxiety | Distress, EmotionalSweden
-
Fertility Centers of IllinoisRush University Medical Center; Pulling Down the Moon, Holistic HealthUnknownAnxiety | Infertility, FemaleUnited States
-
University Hospital TuebingenUniversity of Hohenheim; Universität TübingenCompletedObsessive-Compulsive DisorderGermany
-
Our Lady's Hospice and Care ServicesSt Vincent's University Hospital, IrelandEnrolling by invitation
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingTraumatic Brain Injury | Attention Impaired | Emotional RegulationUnited States
-
University of ZurichAmbulatorium für kognitive Verhaltenstherapie und Verhaltensmedizin - UZH; Lamprecht...Not yet recruitingPostpartum Depression | Major Depressive Disorder | Generalized Anxiety | Prenatal AnxietySwitzerland